Sterile precision, built into every dose — a facility centred on injectable manufacturing, paired with a dedicated line for penam-class oral solids, engineered to deliver the safety and consistency that beta-lactam therapy demands.
Injectable manufacturing leaves no margin for error — every dry powder fill must be sterile, accurate and consistent from the first vial to the last. This facility is built around that standard, with a dedicated beta-lactam injectable line supported by an equally focused oral penam line.
Together, these two disciplines let the facility serve a critical class of anti-infective therapy across both oral and injectable routes, without diluting the precision either format demands.
Low rupture hardness tablets, engineered for the specific handling characteristics of penam-class actives.
Dry syrup formats supporting accurate, easier dosing for penam-class antibacterial therapy.
A dedicated sterile line for beta-lactam injectable production, engineered for the accuracy that injectable therapy demands.
Contamination-controlled fill & finish practices applied consistently across the injectable line.
Dedicated penam and beta-lactam production lines translate into focused support for one of the most widely used categories of anti-infective therapy.
Penam and beta-lactam therapy for a broad spectrum of infections.
Oral and injectable options supporting respiratory tract treatment.
Injectable formats supporting fast-acting, hospital-grade therapy.
Dry syrup formats supporting easier dosing across age groups.
Reach spans many more anti-infective treatment needs, supported by dedicated oral and injectable beta-lactam capability.
Producing beta-lactam medicines safely calls for containment and sterility discipline that goes well beyond standard practice.
Segregated production infrastructure that keeps penam and beta-lactam manufacturing fully independent from other operations.
Precision-controlled aseptic filling for dry powder injectable production, safeguarding sterility from start to finish.
Specialized tablet engineering suited to the handling characteristics of penam-class actives.
Shared standards of accuracy and control applied consistently across both the oral and injectable lines.
Sited within the Siggadi Growth Centre at SIDCUL, Kotdwar, in the Pauri Garhwal district — the facility extends Akums' manufacturing presence into a second Uttarakhand industrial base. Dedicated, discipline-segregated infrastructure allows oral penam and injectable beta-lactam production to each scale independently, without compromise.
Positioned within the Siggadi Growth Centre industrial base at SIDCUL, Kotdwar.
Independent oral penam and injectable beta-lactam production areas.
Facility design built around the containment and sterility needs of injectable manufacturing.
Infrastructure aligned to deliver dependable injectable solutions for patient care.
From dry powder injections to penam tablets and syrups, this facility brings together precision, compliance and scale across every dose it produces. Therapeutic reach continues to expand across many more anti-infective treatment needs.
Plot No. B-6, 7, 8 & 9, Sector-I, Siggadi Growth Centre, SIDCUL, Kotdwar, Distt. Pauri Garhwal-246149, Uttarakhand, India
Akums Healthcare Limited, Kotdwar
Injectable & Penam Manufacturing
This facility manufactures penam-class oral solids (low rupture hardness tablets, dry syrups) on a dedicated oral line, and beta-lactam dry powder injections on a dedicated sterile injectable line.
The facility is located at Plot No. B-6, 7, 8 & 9, Sector-I, Siggadi Growth Centre, SIDCUL, Kotdwar, Distt. Pauri Garhwal-246149, Uttarakhand, India — extending Akums' manufacturing footprint beyond Haridwar.
Yes. The facility runs segregated, dedicated infrastructure so oral penam and injectable beta-lactam production can each scale independently, without compromising sterility or containment discipline.
This facility supports bacterial infection treatment broadly, along with respiratory infections, acute & hospital care, and paediatric care through dry syrup formats.
Yes. This facility supports third-party and contract manufacturing programs across its oral penam and beta-lactam injectable lines. Reach out via the form below to discuss your project requirements.
Partner with Akums to elevate your pharmaceutical, nutraceutical, and cosmetic supply chain. As India's leading CDMO, we offer end-to-end solutions, including R&D, formulation development, and large-scale manufacturing. Our state-of-the-art facilities comply with stringent global standards, ensuring product safety, efficacy, and quality. With a strong focus on innovation, we deliver tailored solutions to meet your unique business needs. Whether you're launching a new product or enhancing your current supply chain, Akums provides reliable expertise, seamless scalability, and unwavering commitment to excellence. Join hands with Akums to strengthen your brand and achieve sustained growth in competitive markets.